What Hims & Hers Can Teach Healthtech Executives About Growth > 자유게시판

Scaling a healthtech company isn’t just about growth—it’s about building a business that buyers trust and value when it’s time to exit. That’s where lessons from Hims & Hers come in.

The Blurred Line Between D2C and B2B

Executives once believed direct-to-consumer tactics had little place in B2B healthtech. But as buyer behavior evolves, successful companies are adapting D2C strategies to build trust faster.

Take Hims & Hers. Many see it as a niche healthcare startup. In reality, it’s a masterclass in re-engineering the buyer journey—all in a market that traditionally moves slowly.

3 Lessons from a $2B Brand

Make Buying Simple

• 
  
• Transparent pricing built trust immediately.
  
• They let customers skip the sales gatekeepers.
  
• The healthcare experience felt more like retail shopping than a traditional clinic.
  

2. Trust Arbitrage

• 
  
• Organic reach and collaboration created steady demand.
  
• They leveraged influencers and respected brands to boost credibility.
  
• Content empowered buyers to learn, decide, and trust before they ever spoke to sales.
  

Predictable Growth

• 
  
• Simple onboarding kept adoption high.
  
• Subscription models created predictable cash flow.
  
• They started in a niche, then expanded to new verticals.
  

Applying These Lessons to Your Company

Potential acquirers and investors do their homework long before a meeting. Here’s what matters now:

• 
  
• Make pricing, ROI, and proof of value easy to find—don’t force a sales call.
  
• The easier it is to engage, the higher your valuation.
  
• Executives, CIOs, and clinicians are your best advocates.
  
• Peer-led validation beats cold outreach.
  

Looking Ahead

Most healthtech companies still struggle with legacy models. But those who adopt modern growth strategies will increase their exit value.

"If people like you, they’ll listen. If they trust you, they’ll do business with you." — Zig Ziglar

Trust now starts long before the sales process. For mid-market executives planning their next chapter, that’s the key to attracting the right buyers.

Partner with Legacy DNA

At Legacy DNA, we help healthtech executives refine positioning, accelerate growth, and maximize exit outcomes. Ready to map out your best path forward?

Let’s start the conversation.